Current state of our knowledge on brain tumor epidemiology

Current Neurology and Neuroscience Reports

Volumn 11, Issue 3, 2011, Pages 329-335

  Ostrom, Quinn T ^a   Barnholtz Sloan, Jill S ^b  

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

^b CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Acoustic neuromas; Brain tumor; Cell phone; Epidemiology; Genome wide association study (GWAS); Genomics Somatic changes; Glioma; Meningiomas; Risk factors

Indexed keywords

ARTICLE; BRAIN TUMOR; CANCER EPIDEMIOLOGY; CANCER GENETICS; CANCER RISK; GENETIC ASSOCIATION; GENETIC RISK; GENOTYPE; GLIOBLASTOMA; HUMAN; MENINGIOMA; MOBILE PHONE; ONCOGENE; RADIATION HAZARD; RADIOFREQUENCY RADIATION; RISK FACTOR; RTEL1 GENE; SINGLE NUCLEOTIDE POLYMORPHISM; TERT GENE; ELECTROMAGNETIC FIELD; GENETICS; IONIZING RADIATION; PATHOLOGY; REVIEW;

BRAIN NEOPLASMS; CELLULAR PHONE; ELECTROMAGNETIC FIELDS; GENOME-WIDE ASSOCIATION STUDY; HUMANS; POLYMORPHISM, SINGLE NUCLEOTIDE; RADIATION, IONIZING; RISK FACTORS;

EID: 79961155049     PISSN: 15284042     EISSN: 15346293     Source Type: Journal    
DOI: 10.1007/s11910-011-0189-8     Document Type: Article

References (50)

1. CBTRUS. Statistical Report: Primary Brain Tumors in the United States, 2004-2006. Chicago: Central Brain Tumor Registry of the United States; 2010.
2. Wrensch M, Minn Y, Chew T, et al. Epidemiology of primary brain tumors: current concepts and review of the literature. Neuro Oncol. 2002;4:278-99.
3. Ohgaki H, Kleihues P. Epidemiology and etiology of gliomas. Acta Neuropathol (Berl). 2005;109(1):93-108. (Pubitemid 40287792)
4. Bondy ML, Scheurer ME, Malmer B, et al. Brain tumor epidemiology: consensus from the Brain Tumor Epidemiology Consortium. Cancer. 2008;113(7 Suppl):1953-68.
5. Shete S, Hosking FJ, Robertson LB, et al. Genome-wide association study identifies five susceptibility loci for glioma. Nat Genet. 2009;41(8):899-904.
6. WrenschM, Jenkins RB, Chang JS, et al. Variants in the CDKN2B and RTEL1 regions are associated with high-grade glioma susceptibility. Nat Genet. 2009;41(8):905-8.
7. The INTERPHONE Study Group: Brain tumour risk in relation to mobile telephone use: results of the INTERPHONE international case-control study. Int J Epidemiol. 2010;39(3):675-94.
8. Law ME, Templeton KL, Kitange G, et al. Molecular cytogenetic analysis of chromosomes 1 and 19 in glioma cell lines. Cancer Genet Cytogenet. 2005;160(1):1-14. (Pubitemid 40798130)
9. Thomas C, Ely G, James CD, et al. Glioblastoma-related gene mutations and over-expression of functional epidermal growth factor receptors in SKMG-3 glioma cells. Acta Neuropathol (Berl). 2001;101(6):605-15. (Pubitemid 32684760)
10. Smith JS, Tachibana I, Lee HK, et al. Mapping of the chromosome 19 q-arm glioma tumor suppressor gene using fluorescence in situ hybridization and novel microsatellite markers. Genes Chromosom Cancer. 2000;29(1):16-25. (Pubitemid 30620494)
11. Wiencke JK, Aldape K, McMillan A, et al. Molecular features of adult glioma associated with patient race/ethnicity, age, and a polymorphism in O6-methylguanine-DNA-methyltransferase. Cancer Epidemiol Biomark Prev. 2005;14(7):1774-83. (Pubitemid 40995094)
12. Kleihues P, Ohgaki H. Genetics of glioma progression and the definition of primary and secondary glioblastoma. Brain Pathol. 1997;7:1131-6. (Pubitemid 127742963)
13. Kleihues P, Ohgaki H. Primary and secondary glioblastomas: from concept to clinical diagnosis. Neuro Oncol. 1999;1(1):44-51.
14. Kleihues P, Ohgaki H. Phenotype vs genotype in the evolution of astrocytic brain tumors. Toxicol Pathol. 2000;28(1):164-70. (Pubitemid 30078219)
15. Berens ME, Giese A. "⋯ those left behind." Biology and oncology of invasive glioma cells. Neoplasia. 1999;1(3):208-19.
16. Berens ME, Rutka JT, Rosenblum ML. Brain tumor epidemiology, growth, and invasion. Neurosurg Clin N Am. 1990;1(1):1-18.
17. Ohgaki H, Dessen P, Jourde B, et al. Genetic pathways to glioblastoma: a population-based study. Cancer Res. 2004;64 (19):6892-9. (Pubitemid 39330996)
18. The Cancer Genome Atlas Research Network. Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature. 2008;455(7216):1061-8.
19. Bredel M, Scholtens DM, Harsh GR, et al. A network model of a cooperative genetic landscape in brain tumors. JAMA. 2009;302 (3):261-75.
20. Cowin PA, Anglesio M, Etemadmoghadam D, Bowtell DD. Profiling the cancer genome. Annu Rev Genomics Hum Genet. 2010;11:133-59.
21. Gonzalez-Angulo AM, Hennessy BT, Mills GB. Future of personalized medicine in oncology: a systems biology approach. J Clin Oncol. 2010;28(16):2777-83.
22. Verhaak RG, Hoadley KA, Purdom E, et al. Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1. Cancer Cell. 2010;17(1):98-110.
23. Phillips HS, Kharbanda S, Chen R, et al. Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis. Cancer Cell. 2006;9(3):157-73. (Pubitemid 43357943)
24. Freije WA, Castro-Vargas FE, Fang Z, et al. Gene expression profiling of gliomas strongly predicts survival. Cancer Res. 2004;64(18):6503-10. (Pubitemid 39297907)
25. Nutt CL, Mani DR, Betensky RA, et al. Gene expression-based classification of malignant gliomas correlates better with survival than histological classification. Cancer Res. 2003;63(7):1602-7. (Pubitemid 36373650)
26. Li A, Walling J, Ahn S, et al. Unsupervised analysis of transcriptomic profiles reveals six glioma subtypes. Cancer Res. 2009;69(5):2091-9.
27. Rich JN, Hans C, Jones B, et al. Gene expression profiling and genetic markers in glioblastoma survival. Cancer Res. 2005;65 (10):4051-8. (Pubitemid 40775641)
28. Lee Y, Liu J, Patel S, et al. Genomic landscape of meningiomas. Brain Pathol. 2010;20(4):751-62.
29. Auvinen A, Hietanen M, Luukkonen R, Koskela RS. Brain tumors and salivary gland cancers among cellular telephone users. Epidemiology. 2002;13(3):356-9. (Pubitemid 34415858)
30. Christensen HC, Schuz J, Kosteljanetz M, et al. Cellular telephones and risk for brain tumors: a population-based, incident case-control study. Neurology. 2005;64(7):1189-95.
31. Hardell L, Carlberg M, Hansson Mild K. Pooled analysis of two case-control studies on use of cellular and cordless telephones and the risk for malignant brain tumours diagnosed in 1997-2003. Int Arch Occup Environ Health. 2006;79 (8):630-9. (Pubitemid 44227704)
32. Hepworth SJ, Schoemaker MJ, Muir KR, et al. Mobile phone use and risk of glioma in adults: case-control study. BMJ. 2006;332 (7546):883-7.
33. Hours M, Bernard M, Montestrucq L, et al. Cell Phones and Risk of brain and acoustic nerve tumours: the French INTERPHONE case-control study. Rev Épidémiol Santé Publique. 2007;55 (5):321-32. (Pubitemid 47542359)
34. Inskip PD, Tarone RE, Hatch EE, et al. Cellular-telephone use and brain tumors. N Engl J Med. 2001;344(2):79-86. (Pubitemid 32052496)
35. Klaeboe L, Blaasaas KG, Tynes T. Use of mobile phones in Norway and risk of intracranial tumours. Eur J Cancer Prev. 2007;16(2):158-64.
36. Lahkola A, Auvinen A, Raitanen J, et al. Mobile phone use and risk of glioma in 5 North European countries. Int J Cancer. 2007;120(8):1769-75. (Pubitemid 46399364)
37. Lonn S, Ahlbom A, Hall P, Feychting M. Long-term mobile phone use and brain tumor risk. Am J Epidemiol. 2005;161 (6):526-35. (Pubitemid 40349908)
38. Muscat JE, Malkin MG, Thompson S, et al. Handheld cellular telephone use and risk of brain cancer. JAMA. 2000;284 (23):3001-7. (Pubitemid 32014736)
39. Schuz J, Bohler E, Berg G, et al. Cellular phones, cordless phones, and the risks of glioma and meningioma (Interphone Study Group, Germany). Am J Epidemiol. 2006;163(6):512-20.
40. Takebayashi T, Varsier N, Kikuchi Y, et al. Mobile phone use, exposure to radiofrequency electromagnetic field, and brain tumour: a case-control study. Br J Cancer. 2008;98(3):652-9. (Pubitemid 351214534)
41. Hardell L, Carlberg M, Hansson Mild K. Pooled analysis of two case-control studies on the use of cellular and cordless telephones and the risk of benign brain tumours diagnosed during 1997-2003. Int J Oncol. 2006;28(2):509-18.
42. Brain tumour risk in relation to mobile telephone use: results of the INTERPHONE international case-control study. Int J Epidemiol. 39(3):675-94.
43. Lahkola A, Salminen T, Raitanen J, et al. Meningioma and mobile phone use-a collaborative case-control study in five North European countries. Int J Epidemiol. 2008;37(6):1304-13.
44. Christensen HC, Schuz J, Kosteljanetz M, et al. Cellular telephone use and risk of acoustic neuroma. Am J Epidemiol. 2004;159 (3):277-83. (Pubitemid 38141657)
45. Lonn S, Ahlbom A, Hall P, Feychting M. Mobile phone use and the risk of acoustic neuroma. Epidemiology. 2004;15(6):653-9. (Pubitemid 40424544)
46. Muscat JE, Malkin MG, Shore RE, et al. Handheld cellular telephones and risk of acoustic neuroma. Neurology. 2002;58 (8):1304-6. (Pubitemid 34411885)
47. Schlehofer B, Schlaefer K, Blettner M, et al. Environmental risk factors for sporadic acoustic neuroma (Interphone Study Group, Germany). Eur J Cancer. 2007;43(11):1741-7. (Pubitemid 47042377)
48. Schoemaker MJ, Swerdlow AJ, Ahlbom A, et al. Mobile phone use and risk of acoustic neuroma: results of the Interphone casecontrol study in five North European countries. Br J Cancer. 2005;93(7):842-8. (Pubitemid 41486448)
49. Takebayashi T, Akiba S, Kikuchi Y, et al. Mobile phone use and acoustic neuroma risk in Japan. Occup Environ Med. 2006;63 (12):802-7. (Pubitemid 46024929)
50. Warren HG, Prevatt AA, Daly KA, Antonelli PJ. Cellular telephone use and risk of intratemporal facial nerve tumor. Laryngoscope. 2003;113(4):663-7. (Pubitemid 36406916)